AzTrials
AzTrials

Dietary HabitsIDDPNCT04690907

Intervention, Dietary, Diabetes, Pregnancy

A study testing Dietary intervention in people with Dietary Habits and Obesity, run by University of Eastern Finland at 2 sites in Finland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this rct -study is to explore the effect of a dietary intervention for overweight (body maas index BMI≥25) and obese (BMI≥30) pregnant women on gestational weight gain and the prevalence of gestational diabetes. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Dietary Habits, Obesity, Gestational Diabetes
What is being tested?
Dietary intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
33 participants
Where
2 sitesFinland
Study dates
3 Dec 2020to 31 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • BMI 25 or higher
  • healthy, no chronic medical conditions that can prevent participating to the study
  • singleton pregnancy
  • first trimester of pregnancy at the time of recruitment

Who cannot join

  • BMI less than 25
  • chronic medical conditions
  • multiple pregnancy
  • pregnancy at second or third trimester at the time of recruitment

Trial locations and contacts

2 sites in 1 country.

Finland2 sites
  • Antenatal maternity care clinics (n=6)

    Joensuu

  • Antenatal maternity care clinics (n=12)

    Kuopio

Other trials in Finland

About this study

Official title: Dietary Intervention for Obese Pregnant Women - a Randomized Controlled Trial

The aim of this rct -study is to explore the effect of a dietary intervention for overweight (body maas index BMI≥25) and obese (BMI≥30) pregnant women on gestational weight gain and the prevalence of gestational diabetes.

Read the detailed description

Pregnant women are recruited for the study from 18 maternity care clinics in Northern Savo and Northern Karelia area. The participants will be randomized into intervention and control groups. All the participants will have access to the study web-pages, which includes written material of healthy diet during pregnancy as well as all the study material (4 day food records, Three factor eating questionnaire (TFEQ R-18) and Binge Eating Scale (BES)). In addition, intervention group will get two virtual dietary counseling sessions by a dietician. The information on participants' gestational weight gain and the result of oral glucose tolerance tests will be collected by the public health nurses after birth.

Being tested
Dietary intervention
Medical subject headings
Feeding Behavior, Obesity, Diabetes, Gestational, Gestational Weight Gain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dietary interventionBehavioural

    Written material on healthy diet during pregnancy and 2 virtual dietary counseling sessions.

Study groups in NCT04690907
Study groupRoleWhat they receive
Intervention groupExperimentalDietary intervention: Written material on healthy diet during pregnancy, 2 virtual dietary counseling sessions given by a dietician. Otherwise basic care and counseling at maternity care clinics.
Receives: Behavioral: Dietary intervention
Control groupNo interventionWritten material on healthy diet during pregnancy, otherwise basic care and counseling at maternity care clinics.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gestational weight gain (GWG)

    gestational weight gain (from pre-pregnancy weight until childbirth), measured at maternity care clinic.

    Measured: immediately after the intervention

Secondary outcomes (4)
  1. Gestational diabetes mellitus (GDM)

    GDM is measured by the result of an oral glucose tolerance test (OGTT)

    Measured: immediately after the intervention

  2. Eating habits I

    eating habits are measured by 4 day food records

    Measured: During the intervention up to gestational weeks 36-37

  3. Eating habits II

    Eating habits are measured by TFEQ R-18 questionnaire

    Measured: During the intervention up to gestational weeks 37-42

  4. Eating habits III

    Eating habits are measured by Binge Eating Scale (BES)

    Measured: During the intervention up to gestational weeks 37-42

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Dec 2020
  2. Study start3 Dec 2020
  3. Primary completion31 Oct 2022
  4. Study completion31 Dec 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Intervention group and control group.
Masking
None (open label)
Enrolment
33 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04690907
Sponsor's protocol ID
031220
Acronym
IDDP
Status last verified
Nov 2023
First submitted
3 Dec 2020
Last updated
29 Nov 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Dietary intervention in people with Dietary Habits and Obesity, run by University of Eastern Finland at 2 sites in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gestational weight gain (GWG) (time frame: immediately after the intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Nov 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in